RxDoctor Payments Data

Kyla Crispe, PA

Medical · Mansfield, TXNPI 1740736099

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $14,113 of the $21,949 with a category attached, or 64.3%. 34 manufacturers reported payments, led by Galderma Laboratories, L.p. at 35.7% of the total. 2025 is the largest year on record at $10,924, 6.5 times the $1,669 reported in 2021. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,949in general payments, 2019–2025

Across 708 payments — averaging $31.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$8K
  • AbbVie$3K
  • Novartis$2K
  • Sanofi$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • Johnson & Johnson$986
  • plus $7K from 28 others

What the payments were for

  • Speaking & faculty fees$7,27533%
  • Food & beverage$14,11364%
  • Education$5613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,949 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Medicare billing

Part B allowed, 2024
$169,616
Medicare patients
632
Services billed
3,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab34$120,087
Dupixent PenDupilumab29$102,142
Clobetasol Propionate49$1,492
Ketoconazole111$1,471
Doxycycline Hyclate75$1,341
Mupirocin147$1,271
Triamcinolone Acetonide65$630
Minoxidil59$484
Clindamycin Phosphate16$470
Mometasone Furoate17$367
Cephalexin30$215
Doxycycline Monohydrate14$191
MethotrexateMethotrexate Sodium11$24

Paid to pharmacies, not to this prescriber.

Other medical in Mansfield

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →